Thought Leadership and Case Studies

Competitive intelligence is essential for pharmaceutical product launches. Even the most promising therapies can fail if market dynamics are misjudged or emerging risks are ignored. Scientific innovation and regulatory approval are necessary milestones, but commercial success depends on the ability to correctly interpret competitor activity, customer needs, payer expectations, and market conditions. Many unsuccessful launches […]

Pharma insights teams have evolved from supporting business functions to becoming strategic partners that influence critical decisions across the pharmaceutical product lifecycle. From identifying market opportunities and monitoring competitors to supporting product launches and forecasting future demand, these teams provide the intelligence organizations need to make informed decisions. However, as their role becomes more influential, […]

A successful pharma product launch is the result of years of planning, scientific research, regulatory preparation, and commercial execution. While innovative therapies often receive the spotlight, it is the collaboration of multiple stakeholders that determines whether a product succeeds in the market. From research and development through commercialization and post-launch monitoring, every team contributes specialized […]

Regulatory change is a permanent driver of change in the pharmaceutical industry. It affects clinical development, product approvals, market access, and commercial strategy. Pharmaceutical market research teams need to stay abreast of changing regulations to provide trustworthy insights that also meet local and global compliance. With new policies from governments and regulatory agencies around data […]

Early-stage insights can make a huge difference in the future success of a biotechnology company. Scientific innovation is the basis for every new therapy, but commercial success often depends on understanding market needs long before a product is approved for clinical use. Those who invest early in market research are better positioned to sharpen their […]

Diagnostics innovation is entering a new era, fueled by progress in artificial intelligence, molecular testing, digital health, and precision medicine. Healthcare is becoming more personalized, and diagnostic technologies are evolving from simple disease detection to enabling earlier intervention, treatment selection, and continuous patient monitoring. These innovations provide useful insights for pharmaceutical companies to improve clinical […]

Insight silos are one of the most common barriers preventing pharmaceutical organizations from making fast, informed decisions. Market research, medical affairs, commercial teams, regulatory specialists, and data analytics departments often generate valuable insights independently, yet these findings frequently remain isolated within their own functions — a problem cross-functional collaboration is meant to solve. The result […]

Medical affairs and commercial collaboration are reshaping how pharmaceutical companies generate valuable insights across the product lifecycle. Traditionally, medical affairs and commercial teams operated with separate objectives and responsibilities. Today, however, the increasing complexity of healthcare, evolving patient expectations, and growing demand for data-driven decision-making require stronger collaboration between these functions. By working together while […]

Patient voice has become a more and more valuable part of pharmaceutical forecasting. Traditional peak sales models rely on historical market data, epidemiology, prescribing patterns, competitive intelligence, and pricing assumptions. These inputs remain important, but they don’t always include the real-world patient experiences, preferences, and treatment decisions that drive product adoption. Pharmaceutical organisations that include […]